You just read:

Rakuten Medical Releases Phase 2a Study Data during ASCO Annual Meeting Highlighting Positive Safety Profile and Clinically Meaningful Anti-tumor Activity

News provided by

Rakuten Medical, Inc.

Jun 01, 2019, 14:20 ET